J D Bitran|J E Ultmann - JoVE Visualize

Showing results (41-50 of 125) with videos related to

Pageof 13

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985

Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institutionE R Gaynor, J E Ultmann, H M Golomb, et al.

Cancer Investigation|January 1, 1988

The role of high-dose therapy and autologous bone marrow reinfusion in the treatment of malignant lymphomasS F Williams, R L Schilsky, J E Ultmann, et al.

Cancer Treatment Reports|May 1, 1982

Prognostic significance of the Lukes and Collins classification in patient treated with COMLAD L Sweet, R D Collins, R S Stein, et al.

Cancer|November 1, 1981

Multiple histologic subtypes of non-Hodgkin's lymphoma: clinical and pathologic featuresS Leyser, D Variakojis, U Mintz, et al.

Seminars in Nuclear Medicine|July 1, 1980

Gallium-67 citrate imaging studies of the lungC Bekerman, P B Hoffer, J D Bitran, et al.

Cancer|October 1, 1978

Scintigraphic evaluation of sarcomata in children and adults by Ga67 citrateJ D Bitran, C Bekerman, H M Golomb, et al.

JAMA|December 15, 1978

Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP)J D Bitran, R K Desser, T DeMeester, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1995

A phase I study of ifosfamide and doxorubicin with recombinant human granulocyte colony-stimulating factor in stage IV breast cancerJ D Bitran, B L Samuels, S Marsik, et al.

American Journal of Clinical Oncology|February 1, 1995

A phase II study of recombinant interferon-gamma following combination chemotherapy for patients with extensive small cell lung cancer. CALGBJ D Bitran, M Green, M Perry, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996

Her2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IIIA breast cancer (>10 involved lymph nodes) treated with high-dose chemotherapy and autologous hematopoietic progenitor cell support following standard-dose adjuvant chemotherapyJ D Bitran, B Samuels, Y Trujillo, et al.

Pageof 13

Showing results (41-50 of 125) with videos related to

Sort By:

Pageof 13

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985

Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institutionE R Gaynor, J E Ultmann, H M Golomb, et al.

Cancer Investigation|January 1, 1988

The role of high-dose therapy and autologous bone marrow reinfusion in the treatment of malignant lymphomasS F Williams, R L Schilsky, J E Ultmann, et al.

Cancer Treatment Reports|May 1, 1982

Prognostic significance of the Lukes and Collins classification in patient treated with COMLAD L Sweet, R D Collins, R S Stein, et al.

Cancer|November 1, 1981

Multiple histologic subtypes of non-Hodgkin's lymphoma: clinical and pathologic featuresS Leyser, D Variakojis, U Mintz, et al.

Seminars in Nuclear Medicine|July 1, 1980

Gallium-67 citrate imaging studies of the lungC Bekerman, P B Hoffer, J D Bitran, et al.

Cancer|October 1, 1978

Scintigraphic evaluation of sarcomata in children and adults by Ga67 citrateJ D Bitran, C Bekerman, H M Golomb, et al.

JAMA|December 15, 1978

Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP)J D Bitran, R K Desser, T DeMeester, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1995

A phase I study of ifosfamide and doxorubicin with recombinant human granulocyte colony-stimulating factor in stage IV breast cancerJ D Bitran, B L Samuels, S Marsik, et al.

American Journal of Clinical Oncology|February 1, 1995

A phase II study of recombinant interferon-gamma following combination chemotherapy for patients with extensive small cell lung cancer. CALGBJ D Bitran, M Green, M Perry, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996

Her2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IIIA breast cancer (>10 involved lymph nodes) treated with high-dose chemotherapy and autologous hematopoietic progenitor cell support following standard-dose adjuvant chemotherapyJ D Bitran, B Samuels, Y Trujillo, et al.

Pageof 13